For Moderate to Severe acne, CAB gel turns out to be effective treatment suggests a study published in the Journal of Drugs ...

Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...

Dare Bioscience Inc (DARE) secures significant funding and progresses with FDA interactions, despite facing increased ...

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...

today announced the approval by Health Canada of PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) ... For Fifth Consecutive Year, 10 Students with Gastrointestinal Disease Will ...

She also notes that sarecycline has less effect on the gut than other oral antibiotics, such as clindamycin phosphate, which is also prescribed for inflammatory and cystic acne. Harper also ...

These include benzoyl peroxide plus clindamycin, benzoyl peroxide plus ... patients must have hematologic monitoring. A glucose-6-phosphate dehydrogenase level must be normal before beginning ...

Brian Kemp Dolliver; Analyst; Brookline Capital Markets Douglas Tsao; Analyst; H.C. Wainwright & Co LLC ...

As of the date of this press release, the commercial assets in XOMA Royalty’s milestone and royalty portfolio are VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafenib), MIPLYFFA™ (arimoclomol), XACIATO™ ...

XOMA Royalty (XOMA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. XOMA Royalty ...

intense pulsed light (IPL), pulsed dye lasers (PDL), potassium titanyl phosphate lasers, infrared diode lasers and photodynamic therapy (PDT) with or without photosensitizing agents ...